AAP reports a narrower-than-expected Q4 loss and expects 2025 net sales from continuing operations in the range of $8.4-$8.6 ...

Xenon Pharmaceuticals XENE reported a loss of 84 cents per share for the fourth quarter of 2024, narrower than the Zacks ...

Nvidia shares fell Thursday morning, as a somewhat muted post-results session kicked off. The AI chip maker's stock is ...

National Vision Holdings, Inc. EYE delivered a loss of 4 cents in the fourth quarter of 2024 compared with the year-ago ...

I'm glad I didn't spend money on a high-end foldable phone that costs twice as much, like the Galaxy Z Fold 6 we reviewed in ...

Xenon Pharmaceuticals XENE reported a loss of 84 cents per share for the fourth quarter of 2024, narrower than the Zacks Consensus Estimate of a loss of 89 cents. The company had incurred a loss ...

Novavax NVAX incurred a fourth-quarter 2024 loss of 51 cents per share, narrower than the Zacks Consensus Estimate of a loss of 75 cents. In the year-ago quarter, the company reported a loss of $1 ...

With rumors that the Razr Plus 2025 is on the way, we discuss why it needs to adopt an ultrawide camera instead of a ...